Dr Evans presents results from a study on the use of a novel, noninvasive imaging tool that allows researchers to measure free prostate-specific antigen in prostate cancer models and to visualise bone metastasis in a tumour-specific manner.
The results were presented at the AACR 2012 Annual meeting in Chicago.
ecancerNews Coverage: Novel technology allows for noninvasive imaging of prostate cancer